1. A comparative investigation of methods for longitudinal data with limits of
    detection through a case study.
  2. Acute aflatoxicosis: case report.
  3. Aflatoxicosis: health implications.
  4. AIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and
    Realities of Therapeutic Approach.
  5. Anatomical site predilections of non-Hodgkin's lymphoma in human immunodeficiency virus infection: a report on 54 cases
  6. Aspects of epidemiological and clinical features of patients with central nervous system Burkitt's lymphoma in Kenya
  7. Autologous transfusion in surgical patients at Kenyatta National Hospital,
  8. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at
    posttranscriptional level by miRNA-altered expression.
  9. Building capacity in implementation science research training at the University of Nairobi
  10. Burkitt's lymphoma: the initial defining characteristics.
  11. Burkitt's lymphoma and emerging therapeutic strategies for EBV and
    AIDS-associated lymphoproliferative diseases in East Africa.
  12. Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution
  13. Burkitt's lymphoma in Kenya: views from the 20th century
  14. Cancers in children younger than age 16 years in Kenya.
  15. Challenges in the epidemiological and clinical aspects of Burkitt's lymphoma in Kenya: linking evidence and experience.
  16. Childhood aplastic anaemia in Kenya.
  17. Clinical characteristics of Burkitt's lymphoma seen in Kenyan patients.
  18. Clinico-pathologic characteristics and treatment outcomes in children with
    neuroblastoma at the Kenyatta National Hospital, Nairobi.
  19. A comparative investigation of methods for longitudinal data with limits of
    detection through a case study.
  20. Comparing walk-in and call-responsive donors in a national and a private hospital in Nairobi.
  21. Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva.
  22. Developing clinical strength-of-evidence approach to define HIV-associated
    malignancies for cancer registration in Kenya.
  23. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa